相关实验视频

Updated: Jul 17, 2025

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

Published on: July 25, 2019

专用双分支架支架系统的临床结果

Jegan Sivalingam¹, Muhammad Waqas Mazhar², Rima Ayoub Chaddad³

¹Hannah Joseph Hospital, Madurai, India; DCB Academy, Milano, Italy.

Cardiovascular revascularization medicine : including molecular interventions

|September 4, 2023

概括

通过皮肤冠状动脉干预 (PCI) 用BiOSS LIM C支架治疗分叉病变,尽管植入成功,但其主要目标是病变再血管化,但其主要心脏不良事件的发生率很高.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
生物材料科学生物材料科学

背景情况:

通过皮肤冠状动脉干预 (PCI) 治疗双叉病变带来了重大的技术挑战.
这些手术与支架血栓形成和支架内静止症的风险增加有关.

研究的目的:

为了评估BiOSS LIM C专用分叉支架的临床结果.
评估这种支架在冠状动脉疾病患者的安全性和有效性.

主要方法:

一个回顾性单中心研究分析了用BiOSS LIM C支架治疗的双分支冠状动脉疾病患者.
主要终点是最大可用的随访时间内主要心脏不良事件 (MACE) 的累积率.

主要成果:

这项研究包括25名患者,其中80%的患者在左侧冠状动脉中接受了支架.
设备的成功率为100%,没有医院内事件. 在15个月的随访期内,MACE的中位数为56%,其中55%是临床驱动的目标损伤再血管化 (TLR).

结论:

BiOSS LIM C 支架在主要冠状动脉分叉病变,特别是左主干中显示出中期重大不良事件的高发病率.
目标病变的再血管化是不良事件的主要驱动因素,尽管有适当的植入技术.

关键词:

冠状动脉的分支是冠状动脉的分支.专门的分叉支架支架.药物释放的支架可以释放药物.左主干干的主要干.

更多相关视频

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...